Public Health Today—March 13, 2026

This weekly public health update highlights recent research, data analyses and scientific findings shaping health and biomedical science. Topics include antimicrobial resistance, aging biology, disease risk detection, nutrition, neuroscience and emerging infectious disease insights. Together, these developments illustrate ongoing progress in prevention, diagnostics and understanding of disease mechanisms.

In Today’s Newsletter

Dive deeper

🦠 Antibiotic pipeline shrinks as AMR threat grows [1] [10 Mar 2026]

https://www.theguardian.com/business/2026/mar/10/new-drugs-fight-superbugs-uk-gsk-astrazeneca
Context: Access to Medicine Foundation and Wellcome Trust benchmark report assessing antimicrobial R&D across 25 companies.
Key point: Pipeline among large research based pharma fell from 92 to 60 antimicrobial projects over five years (report finding).
Implication: Could inform practice and payer discussions; interpretation depends on study design and confounding control.

🧬 Multivitamin use linked to slower epigenetic ageing [2] [09 Mar 2026]

https://www.nature.com/articles/d41586-026-00741-3
Context: COSMOS randomized trial analysis of 958 older adults with DNA methylation ageing clocks measured at baseline, 12 and 24 months.
Key point: Daily multivitamin associated with modest slowing of biological ageing signals on some epigenetic clocks (clinical endpoints not tested).
Implication: Could inform practice and payer discussions; interpretation depends on study design and confounding control.

🫀 AI reads heart risk from routine mammograms [3] [09 Mar 2026]

https://www.fiercebiotech.com/medtech/ai-could-help-spot-heart-disease-routine-breast-mammogram-screenings
Context: Observational analysis of 123,762 women using AI to quantify breast arterial calcification (BAC) in screening mammograms.
Key point: Severe BAC associated with higher rates of cardiovascular events, independent of traditional risk factors.
Implication: Could streamline initiation and adherence via remote prescribing and logistics.

🧠 Fitness amplifies the brain’s response to exercise [4] [09 Mar 2026]

https://neurosciencenews.com/fitness-levels-bdnf-brain-boost-30279/
Context: UCL led 12 week cycling program in previously inactive adults measuring VO2max, BDNF response and prefrontal activity.
Key point: Improved aerobic fitness increased the post exercise spike in brain derived neurotrophic factor (BDNF).
Implication: Could inform practice and payer discussions; interpretation depends on study design and confounding control.

🧫 Pandemic viruses may emerge without prior adaptation [5] [09 Mar 2026]

https://today.ucsd.edu/story/recent-pandemic-viruses-jumped-to-humans-without-prior-adaptation-uc-san-diego-study-finds
Context: Cell study analyzing evolutionary selection patterns across influenza A, Ebola, Marburg, mpox, SARS CoV and SARS CoV 2.
Key point: Researchers found no evidence of unusual adaptive selection immediately before zoonotic spillover events.
Implication: Could inform practice and payer discussions; interpretation depends on study design and confounding control.

🦠 Gut–brain signaling reverses memory decline in mice [6] [11 Mar 2026]

https://medicalxpress.com/news/2026-03-gut-brain-communication-reverses-cognitive.html
Context: Stanford Medicine and Arc Institute Nature study linking age related microbiome shifts to hippocampus dependent memory impairment.
Key point: Restoring vagus nerve signaling reversed microbiome driven cognitive deficits in aging mice.
Implication: May influence prescriber choice and payer reviews pending full data.

⚖️ Sex differences mapped in GLP-1 brain signaling [7] [10 Mar 2026]

https://neurosciencenews.com/sex-specific-glp1-brain-80284/
Context: Brain Medicine study mapping GLP-1 mRNA expression across brain regions in male and female mice.
Key point: Distinct sex specific expression patterns identified in appetite, reward and metabolic regulation circuits.
Implication: Signals pipeline investment and modality expansion.

🫁 ATF4 identified as lung cancer metastasis driver in ageing [8] [12 Mar 2026]

https://www.news-medical.net/news/20260312/New-protein-target-for-safer-lung-cancer-therapy.aspx
Context: Nature study combining aged mouse models and analysis of ~1,000 Swedish lung cancer patients with KRAS driven disease.
Key point: Elevated ATF4 linked to increased metastasis and poorer outcomes in older lung adenocarcinoma patients.
Implication: May influence prescriber choice and payer reviews pending full data.

🧑‍🤝‍🧑 Stressful relationships linked to faster biological ageing [9] [09 Mar 2026]

https://medicalxpress.com/news/2026-03-difficult-person-life-aging-faster.html
Context: PNAS analysis of >2,000 adults using DNA methylation ageing clocks and social network survey data.
Key point: Greater exposure to “hasslers” associated with higher biological age estimates and faster ageing pace (observational analysis).
Implication: Could inform practice and payer discussions; interpretation depends on study design and confounding control.

🍟 Ultra processed foods in toddlers linked to later behavior [10] [07 Mar 2026]

https://medicaldialogues.in/mdtv/medical-news-today/medical-bulletin-07march2026-166011
Context: JAMA Network Open analysis of 2,077 children in the Canadian CHILD Cohort Study.
Key point: Higher ultra processed food intake at age three associated with slightly higher behavioral symptom scores at age five.
Implication: Could inform practice and payer discussions; interpretation depends on study design and confounding control.

Why it matters

AMR risk remains structurally underfunded, with the antibiotic pipeline shrinking despite rising resistance threats.
Epigenetic ageing biomarkers are increasingly used in human trials, signaling a shift toward measurable healthspan metrics.
Existing screening programs may gain new diagnostic value, as AI tools extract additional health signals from routine imaging.
Microbiome and gut–brain research continues to uncover reversible drivers of cognitive ageing, highlighting peripheral intervention strategies.
Sex specific biology is gaining attention in metabolic drug development, especially for widely used GLP 1 therapies.

🚀 Accelerate your success. Contact us now

📂 Explore our case studies. See examples of our work.

💡 Read our insights. Learn from our latest reports and analysis

🎬 Watch on YouTube. Subscribe and never miss a video.

🧰 See our full range of services. Discover how we can help you.

View the full Public Health archive on our research hub page.

FAQ

What did the Access to Medicine Foundation report say about the antibiotic pipeline?

The report found that antimicrobial R&D projects among large research based pharmaceutical companies declined substantially over five years. It highlights GSK as a leading large company still active in the field while noting a broader reduction in industry engagement. [1]

Does the COSMOS trial show multivitamins slow ageing?

The randomized COSMOS analysis found that daily multivitamin use modestly slowed some DNA methylation based ageing clocks in older adults over two years. Clinical outcomes such as lifespan or disease incidence were not directly tested. [2]

How can mammograms help identify cardiovascular risk?

Researchers used AI to measure breast arterial calcification visible on routine mammograms. Severe calcification was associated with higher risk of cardiovascular events even after adjusting for traditional risk factors. [3]

What does the UC San Diego viral evolution study imply for pandemic preparedness?

The analysis suggests many viruses can infect humans without major adaptive changes before spillover. Risk may therefore depend more on exposure to animal viruses than on rare evolutionary events. [5]

Why is the vagus nerve important in gut–brain ageing research?

The Stanford study found that microbiome driven inflammation reduced vagus nerve signaling, which suppressed hippocampal activity and memory in mice. Stimulating the vagus nerve restored cognitive performance in older animals. [6]

Why do GLP-1 drugs sometimes affect men and women differently?

Researchers mapped sex specific GLP-1 receptor expression across multiple brain regions in mice. Differences in appetite, reward and metabolic circuits may partly explain variations in drug response between sexes. [7]

Entities / Keywords

Access to Medicine Foundation (AMR benchmark)
Wellcome Trust (global health research funding)
COSMOS trial (multivitamin and health outcomes)
Epigenetic clocks (DNA methylation ageing biomarkers)
Breast arterial calcification (BAC) (mammography cardiovascular marker)
UC San Diego viral evolution study (zoonotic spillover analysis)
Parabacteroides goldsteinii (microbiome species linked to cognition)
ATF4 (integrated stress response transcription factor)
GLP-1 signaling (metabolic peptide hormone pathway)
Ultra processed foods (UPFs) (NOVA classification diet category)